ACC 2019 | The New ACC/AHA Guidelines on Primary Prevention Focus on Life Style, Diet and Socioeconomic Factors.

These guidelines basically remind us that we should focus on life style changes to best prevent heart disease, heart failure and atrial fibrillation. These changes, of course, should be permanent.

ACC 2019 | Las nuevas guías de prevención primaria ACC/AHA con foco en estilo de vida, dieta y factores socioeconómicos.It is estimated that life style changes translate into 80% risk reduction of heart disease.

 

These recommendations are based on 9 topics: risk estimation, diet, physical activity, obesity, diabetes, cholesterol, hypertension, giving up smoking and the use of aspirin.

 

Social factors have been one of the most difficult fronts and the one with most impact. Physicians seldom show concern about whether patients can afford the drugs we prescribe, or whether they will be able to follow a healthy diet.


Read also: ACC 2019 | SAFARI: Unexpectedly, Radial Approach Offers No Benefits In STEMI.


Moreover, we should routinely try to detect psychosocial stressors and support our patients with savvy advice.

 

For adults between 40 and 75, we recommend screening for traditional risk factors and estimating cardiovascular risk at 10 years (recommendation class I).

 

For patients between 20 and 39, it is reasonable to assess risk factors every 4 to 6 years (recommendation class IIa).


Read also: ACC 2019 | POET: Oral Antibiotics with Good Long-Term Results for Endocarditis.


Patients presenting intermediate or border risk could be better stratified with other markers such as family history, metabolic syndrome, chronic kidney disease, or C-reactive protein.

 

Guidelines also suggest consuming more vegetables, fruits, legumes, whole grains and fish, as well as warning against the consumption of salt, fired foods, processed meats and sugary drinks.

 

They recommend 150 minutes of moderate activity (walking, swimming, cycling) or 75 minutes of a more vigorous activity, and if neither were possible, at least 10 minutes can make a significant difference.


Read also: ACC 2019 | Having an Infarction at Very Young Age or 10 Years Later Does Not Change Long-Term Mortality.


As regards aspirin, it is not recommended as primary prevention in >70-year individuals, or with increased bleeding risk (recommendation class III). For individuals between 40 and 70, aspirin can be considered if there is high cardiovascular risk or low bleeding risk (recommendation class IIb). For most patients, aspirin is not indicated as primary prevention.

 

Original title: 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease.

Reference: Arnett DK et al. Circulation 2019; Epub ahead of print.

 

Guias-de-prevención-primaria


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...